The role of natural product chemistry in drug discovery
Abstract
Although traditionally natural products have played an important role in drug discovery, in the past few years most Big Pharma companies have either terminated or considerably scaled down their natural product operations. This is despite a significant number of natural product-derived drugs being ranked in the top 35 worldwide selling ethical drugs in 2000, 2001, and 2002. There were 15 new natural product-derived drugs launched from 2000 to 2003, as well as 15 natural product-derived compounds in Phase III clinical trials or registration at the end of 2003. Recently, there has been a renewed interest in natural product research due to the failure of alternative drug discovery methods to deliver many lead compounds in key therapeutic areas such as immunosuppression, anti-infectives, and metabolic diseases. To continue to be competitive with other drug discovery methods, natural product research needs to continually improve the speed of the screening, isolation, and structure elucidation processes, as well addressing the suitability of screens for natural product extracts and dealing with issues involved with large-scale compound supply.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Natural products represent an available source of new drugs, drug leads and chemical entities.
“Natural products represent an available source of new drugs, drug leads and chemical entities [11,12].”
From Marine Natural Products: A Source of Novel Anticancer Drugs (2019) · cites this paper as [11]
Plants contain diverse components that are important sources of biologically active molecules, and essential oils have strong antifungal activity.
“Among the natural products, plants contain diverse components that are important sources of biologically active molecules [50, 133, 134]. In fact, the activity of plant crude extracts against different microorganisms has been reported, that is, strong antifungal activity of some major components of essential oils [135, 136].”
From <i>Candida</i>Infections, Causes, Targets, and Resistance Mechanisms: Traditional and Alternative Antifungal Agents (2013) · cites this paper as [134]
Cites
Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305 · see citing works
Natural products as sources of new drugs over the period 1981–2002
Newman, D. J., Cragg, G. M., & Snader, K. M. (2003) · Journal of Natural Products · doi:10.1021/np030096l · Cited by 3,082 · see citing works
The Combinatorial Synthesis of Bicyclic Privileged Structures or Privileged Substructures
Horton, D. A., Bourne, G. T., & Smythe, M. L. (2003) · Chemical Reviews · doi:10.1021/cr020033s · Cited by 3,017 · see citing works
Ranade, V. (2009) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e31817c941f · Cited by 2,790 · see citing works
Drug Discovery: A Historical Perspective
Drews, J. (2000) · Science · doi:10.1126/science.287.5460.1960 · Cited by 2,768 · see citing works
Target-Oriented and Diversity-Oriented Organic Synthesis in Drug Discovery
Schreiber, S. L. (2000) · Science · doi:10.1126/science.287.5460.1964 · Cited by 2,571 · see citing works
The influence of natural products upon drug discovery (Antiquity to late 1999)
Newman, D. J., Cragg, G. M., & Snader, K. M. (2000) · Natural Product Reports · doi:10.1039/a902202c · Cited by 1,293 · see citing works
A Common Mechanism Underlying Promiscuous Inhibitors from Virtual and High-Throughput Screening
McGovern, S. L., Caselli, E., Grigorieff, N., & Shoichet, B. K. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010533y · Cited by 1,048 · see citing works
The Process of Structure-Based Drug Design
Anderson, A. C. (2003) · Chemistry & Biology · doi:10.1016/j.chembiol.2003.09.002 · Cited by 943 · see citing works
Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors
Tobert, J. A. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1112 · Cited by 878 · see citing works
Experimental Models of Primitive Cellular Compartments: Encapsulation, Growth, and Division
Hanczyc, M. M., Fujikawa, S. M., & Szostak, J. W. (2003) · Science · doi:10.1126/science.1089904 · Cited by 848 · see citing works
The discovery and development of HMG-CoA reductase inhibitors.
Endo, A. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41379-3 · Cited by 847 · see citing works
Combinatorial Synthesis of Small Organic Molecules
Balkenhohl, F., Bussche‐Hünnefeld, C. V. D., Lansky, A., & Zechel, C. (1996) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199622881 · Cited by 726 · see citing works
Mechanism-Based Target Identification and Drug Discovery in Cancer Research
Gibbs, W. W. (2000) · Science · doi:10.1126/science.287.5460.1969 · Cited by 599 · see citing works
Waugh, D. F. (1954) · Advances in protein chemistry · doi:10.1016/s0065-3233(08)60210-7 · Cited by 566 · see citing works
Lee, M. D., Dunne, T. S., Chang, C. C., et al. (1987) · Journal of the American Chemical Society · doi:10.1021/ja00245a051 · Cited by 523 · see citing works
Identification and Prediction of Promiscuous Aggregating Inhibitors among Known Drugs
Seidler, J. A., McGovern, S. L., Doman, T. N., & Shoichet, B. K. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm030191r · Cited by 477 · see citing works
Enfuvirtide: the first therapy to inhibit the entry of HIV-1 into host CD4 lymphocytes
Matthews, T., Salgo, M., Greenberg, M., Chung, J., DeMasi, R. A., & Bolognesi, D. P. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1331 · Cited by 466 · see citing works
A functional genomics approach toward the understanding of secondary metabolism in plant cells
Goossens, A., Häkkinen, S. T., Laakso, I., Seppänen‐Laakso, T., Biondi, S., Sutter, V. D., Lammertyn, F., Nuutila, A. M., Söderlund, H., Zabeau, M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1032967100 · Cited by 406 · see citing works
Naturally-occurring beta-lactamase inhibitors with antibacterial activity
BROWN, A. G., BUTTERWORTH, D., COLE, M., HANSCOMB, G., HOOD, J. D., READING, C., & ROLINSON, G. N. (1976) · The Journal of Antibiotics · doi:10.7164/antibiotics.29.668 · Cited by 399 · see citing works
Application and Limitations of X‐ray Crystallographic Data in Structure‐Based Ligand and Drug Design
Davis, A. M., Teague, S. J., & Kleywegt, G. J. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200200539 · Cited by 386 · see citing works
Generating Diverse Skeletons of Small Molecules Combinatorially
Burke, M. D., Berger, E. M., & Schreiber, S. L. (2003) · Science · doi:10.1126/science.1089946 · Cited by 378 · see citing works
Sticher, O. (2008) · Natural Product Reports · doi:10.1039/b700306b · Cited by 378 · see citing works
Designing screens: how to make your hits a hit
Walters, W. P., & Namchuk, M. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1063 · Cited by 377 · see citing works
Engineering secondary metabolite production in plants
Verpoorte, R., & Memelink, J. (2002) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(02)00308-7 · Cited by 377 · see citing works
Smith, A. L., & Nicolaou, K. C. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm9600398 · Cited by 377 · see citing works
(1999) · Choice Reviews Online · doi:10.5860/choice.36-6288 · Cited by 333 · see citing works
Mycophenolic Acid: A One Hundred Year Odyssey from Antibiotic to Immunosuppressant
Bentley, R. (2000) · Chemical Reviews · doi:10.1021/cr990097b · Cited by 331 · see citing works
Eldridge, G. R., Vervoort, H. C., Lee, C. M., Cremin, P. A., Williams, C. T., Hart, S. M., Goering, M. G., O’Neil-Johnson, M., & Zeng, L. (2002) · Analytical Chemistry · doi:10.1021/ac025534s · Cited by 258 · see citing works
Drugs, leads, and drug-likeness: an analysis of some recently launched drugs
Proudfoot, J. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00244-5 · Cited by 252 · see citing works
The role of natural products in a modern drug discovery program
Strohl, W. R. (2000) · Drug Discovery Today · doi:10.1016/s1359-6446(99)01443-9 · Cited by 234 · see citing works
NMR screening techniques in drug discovery and drug design
Stockman, B. J., & Dalvit, C. (2002) · Progress in Nuclear Magnetic Resonance Spectroscopy · doi:10.1016/s0079-6565(02)00049-3 · Cited by 229 · see citing works
Target selection in drug discovery
Knowles, J., & Gromo, G. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd986 · Cited by 216 · see citing works
Corcoran, O., & Spraul, M. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02749-1 · Cited by 208 · see citing works
(2000) · Springer eBooks · doi:10.1007/978-3-642-60250-4 · Cited by 198 · see citing works
Diversifying microbial natural products for drug discovery
Knight-Connoni, V., Sanglier, J., DiTullio, D., Braccili, S., Bonner, P., Waters, J. K., Hughes, D., & Zhang, L. (2003) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-003-1381-9 · Cited by 198 · see citing works
van Elswijk, D. A., Schobel, U., Lansky, E. S., Irth, H., & van der Greef, J. (2003) · Phytochemistry · doi:10.1016/j.phytochem.2003.07.001 · Cited by 189 · see citing works
Cutting the cost of drug development?
Rawlins, M. D. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1347 · Cited by 187 · see citing works
Reynolds, W. F., & Enríquez, R. G. (2002) · Journal of Natural Products · doi:10.1021/np010444o · Cited by 178 · see citing works
Evaluation of the in vitro antioxidant activity of Mangifera indica L. extract (Vimang)
Mart�nez, G., Delgado, R., P�rez, G., Garrido, G., Sellés, A. J. N., & León, O. S. (2000) · Phytotherapy Research · doi:10.1002/1099-1573(200009)14:6 · Cited by 163 · see citing works
Pure compound libraries; a new perspective for natural product based drug discovery
Bindseil, K. U., Jakupovic, J., Wolf, D., Lavayre, J., Leboul, J., & PYL, D. V. D. (2001) · Drug Discovery Today · doi:10.1016/s1359-6446(01)01856-6 · Cited by 156 · see citing works
Drug prototypes and their exploitation
(1997) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(97)84366-8 · Cited by 147 · see citing works
Modern methods to produce natural-product libraries
Abel, U. R., Koch, C., Speitling, M., et al. (2002) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(02)00338-1 · Cited by 140 · see citing works
Biologically Active Natural Products: Pharmaceuticals
Cutler, S. J., & Cutler, H. G. (2018) · Medical Entomology and Zoology · Cited by 139 · see citing works
Bioactive Compounds from Natural Sources
Tringali, C. (2000) · CRC Press eBooks · doi:10.1201/9781482289268 · Cited by 139 · see citing works
A brief history of novel drug discovery technologies
Gershell, L. J., & Atkins, J. H. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1064 · Cited by 129 · see citing works
Mendola, D. (2003) · Biomolecular Engineering · doi:10.1016/s1389-0344(03)00075-3 · Cited by 129 · see citing works
Saponins in Food, Feedstuffs and Medicinal Plants
(2000) · doi:10.1007/978-94-015-9339-7 · Cited by 124 · see citing works
Synthesis of natural-product-based compound libraries
Wessjohann, L. A. (2000) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(00)00093-4 · Cited by 121 · see citing works
Structure-based screening of low-affinity compounds
Carr, R. A. E., & Jhoti, H. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02245-6 · Cited by 110 · see citing works
Wender, P. A., DeBrabander, J., Harran, P. G., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6624 · Cited by 110 · see citing works
Gemtuzumab ozogamicin in the treatment of acute myeloid leukemia
Giles, F. J., Estey, E. H., & O'Brien, S. M. (2003) · Cancer · doi:10.1002/cncr.11791 · Cited by 110 · see citing works
High Throughput Screening: The Discovery of Bioactive Substances
Devlin, J. P. (1997) · Medical Entomology and Zoology · Cited by 107 · see citing works
Approaches to identify, clone, and express symbiont bioactive metabolite genes
Hildebrand, M., Waggoner, L. E., Lim, G. E., Sharp, K. H., Ridley, C. P., & Haygood, M. G. (2004) · Natural Product Reports · doi:10.1039/b302336m · Cited by 106 · see citing works
Bioactive Compounds from Natural Sources: Isolation, Characterization and Biological Properties
Tringali, C. (2000) · Cited by 104 · see citing works
Cardellina, J. H., Munro, M. H. G., Fuller, R. W., Manfredi, K. P., McKee, T. C., Tischler, M., Bokesch, H. R., Gustafson, K. R., Beutler, J. A., & Boyd, M. R. (1993) · Journal of Natural Products · doi:10.1021/np50097a016 · Cited by 102 · see citing works
LaBonte, J. A., Lebbos, J., & Kirkpatrick, P. N. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1091 · Cited by 102 · see citing works
Stahura, F. L., Godden, J. W., Xue, L., & Bajorath, J. (2000) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci0003303 · Cited by 101 · see citing works
In Quest of Tomorrow’s Medicines
Drews, J. (1999) · Springer eBooks · doi:10.1007/978-1-4612-1404-5 · Cited by 100 · see citing works
Finding the needle in the haystack. The dereplication of natural product extracts
Cordell, G. A., & Shin, Y. G. (1999) · Pure and Applied Chemistry · doi:10.1351/pac199971061089 · Cited by 97 · see citing works
Combinatorial biosynthesis of antimicrobials and other natural products
Rodrı́guez, E. (2001) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(00)00246-0 · Cited by 93 · see citing works
Kirakosyan, A., Sirvent, T., Gibson, D. M., et al. (2004) · Biotechnology and Applied Biochemistry · doi:10.1042/ba20030144 · Cited by 93 · see citing works
Arya, P., Joseph, R., & Chou, D. T. H. (2002) · Chemistry & Biology · doi:10.1016/s1074-5521(02)00105-9 · Cited by 88 · see citing works
Natural products in drug discovery – Creating a new vision
Cordell, G. A. (2002) · Phytochemistry Reviews · doi:10.1023/a:1026094701495 · Cited by 86 · see citing works
Drugs: from discovery to approval
(2004) · Choice Reviews Online · doi:10.5860/choice.41-6569 · Cited by 84 · see citing works
Elyashberg, M. E., Blinov, K. A., Williams, A. J., et al. (2004) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci0341060 · Cited by 84 · see citing works
Drug prototypes and their exploitation
(1997) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(97)90084-7 · Cited by 78 · see citing works
van Elswijk, D. A., Diefenbach, O., van der Berg, S., et al. (2003) · Journal of Chromatography A · doi:10.1016/j.chroma.2003.08.055 · Cited by 75 · see citing works
Steinbeck, C. (2001) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci000407n · Cited by 74 · see citing works
Enzymes in the synthesis of bioactive compounds
García‐Junceda, E., Garcı́a-Garcı́a, J. F., Bastida, Á., et al. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.01.032 · Cited by 72 · see citing works
Bioassay Methods in Natural Product Research and Drug Development
Bohlin, L., & Bruhn, J. G. (1999) · Springer eBooks · doi:10.1007/978-94-011-4810-8 · Cited by 70 · see citing works
(2001) · CRC Press eBooks · doi:10.1201/9780203908570 · Cited by 63 · see citing works
The Impact of Natural Products on Drug Discovery
Grabley, S., & Thiericke, R. (2000) · Springer eBooks · doi:10.1007/978-3-642-60250-4_1 · Cited by 63 · see citing works
A Method for the Dereplication of Natural Product Extracts using Electrospray HPLC/MS
Constant, H. L., & Beecher, C. (1995) · Natural product letters · doi:10.1080/10575639508043158 · Cited by 62 · see citing works
LC-NMR: a new tool to expedite the dereplication and identification of natural products
Bobzin, S. C., Yang, S., & Kasten, T. P. (2000) · Journal of Industrial Microbiology & Biotechnology · doi:10.1038/sj.jim.7000057 · Cited by 62 · see citing works
Natural Products in High Throughput Screening: Automated High-Quality Sample Preparation
Schmid, I., Sattler, I., Grabley, S., et al. (1999) · SLAS DISCOVERY · doi:10.1177/108705719900400104 · Cited by 61 · see citing works
Emerging trends in high-throughput screening
Entzeroth, M. (2003) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(03)00088-2 · Cited by 61 · see citing works
Schenk, T., Breel, G. J., Koevoets, P. L. M., et al. (2003) · SLAS DISCOVERY · doi:10.1177/1087057103255973 · Cited by 56 · see citing works
NMR-based methods and strategies for drug discovery
Salvatella, X., & Giralt, E. (2003) · Chemical Society Reviews · doi:10.1039/b210047a · Cited by 55 · see citing works
Natural Products as Leads for New Pharmaceuticals
Buss, A. D., Cox, B. J., & Waigh, R. D. (2003) · Burger's Medicinal Chemistry and Drug Discovery · doi:10.1002/0471266949.bmc018 · Cited by 54 · see citing works
Stereochemistry of Kahalalide F
Bonnard, I., Manzanares, I., & RINEHART, K. L. J. (2003) · Journal of Natural Products · doi:10.1021/np030334c · Cited by 53 · see citing works
Wender, P. A., Baryza, J. L., Brenner, S. E., et al. (2004) · Current Drug Discovery Technologies · doi:10.2174/1570163043484888 · Cited by 52 · see citing works
Natural product-like combinatorial libraries
Abreu, P. M., & Branco, P. S. (2003) · Journal of the Brazilian Chemical Society · doi:10.1590/s0103-50532003000500002 · Cited by 47 · see citing works
Hardy, L. W., & Peet, N. P. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02969-6 · Cited by 46 · see citing works
Devlin, J. P. (1997) · CRC Press eBooks · doi:10.1201/9781482269802 · Cited by 43 · see citing works
Flow NMR applications in combinatorial chemistry
Keifer, P. A. (2003) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(03)00051-6 · Cited by 41 · see citing works
Validation of Structural Proposals by Substructure Analysis and 13C NMR Chemical Shift Prediction
Meiler, J., Sanli, E., Junker, J., Meusinger, R., Lindel, T., Will, M., Maier, W., & Köck, M. (2002) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci010294n · Cited by 38 · see citing works
Will combinatorial chemistry deliver real medicines?
Myers, P. L. (1997) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(97)80123-1 · Cited by 35 · see citing works
Hembre, R. T., Scott, C. P., & Norton, J. R. (1987) · Journal of the American Chemical Society · doi:10.1021/ja00245a052 · Cited by 35 · see citing works
Stembera, K., Vogel, S., Buchynskyy, A., Ayala, J. A., & Welzel, P. (2002) · ChemBioChem · doi:10.1002/1439-7633(20020603)3:6 · Cited by 31 · see citing works
Microarray Compound Screening (μARCS) to Identify Inhibitors of HIV Integrase
David, C. A., Middleton, T. R., Montgomery, D., et al. (2002) · SLAS DISCOVERY · doi:10.1177/108705710200700309 · Cited by 30 · see citing works
Chapter 28. To market, to market — 2000
Gaudillière, B., Bernardelli, P., & Berna, P. P. (2001) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(01)36068-2 · Cited by 28 · see citing works
Ingkaninan, K., Hazekamp, A., Hoek, A. C., et al. (2000) · Journal of Liquid Chromatography & Related Technologies · doi:10.1081/jlc-100100481 · Cited by 28 · see citing works
SEPARATION OF CRUDE PLANT EXTRACTS WITH HIGH SPEED CCC FOR PRIMARY SCREENING IN DRUG DISCOVERY
Armbruster, J. A., Borris, R. P., Jiménez, Q., et al. (2001) · Journal of Liquid Chromatography & Related Technologies · doi:10.1081/jlc-100104382 · Cited by 28 · see citing works
The evolution of microarrayed compound screening
Hoever, M., & Zbinden, P. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03037-5 · Cited by 27 · see citing works
Chapter 26. To market, to market - 2001
Bernardelli, P., Gaudillière, B., & Vergne, F. (2002) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(02)37027-1 · Cited by 26 · see citing works
Chapter 34. To Market, To Market - 1995
Cheng, X. (1996) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(08)60473-x · Cited by 24 · see citing works
Interference of Linoleic Acid Fraction in Some Receptor Binding Assays
Ingkaninan, K., Künzel, J. K. V. F. D., IJzerman, A. P., et al. (1999) · Journal of Natural Products · doi:10.1021/np9805490 · Cited by 24 · see citing works
Chapter 33. To market, to market - 2002
Boyer-Joubert, C., Lorthiois, E., & Moreau, F. (2003) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(03)38034-0 · Cited by 23 · see citing works
Phillipson, D. W., Milgram, K. E., Yanovsky, A. I., et al. (2002) · Journal of Combinatorial Chemistry · doi:10.1021/cc020042e · Cited by 22 · see citing works
The Elusive Magic Bullet: The Search for the Perfect Drug
Mann, J., & Mann, J. (1999) · Cited by 21 · see citing works
Biodiversity law has had some unintended effects
Pethiyagoda, R. S. (2004) · Nature · doi:10.1038/429129a · Cited by 21 · see citing works
The History of Penicillin Production
Parascandola, J., & Elder, A. E. (1971) · Technology and Culture · doi:10.2307/3102547 · Cited by 20 · see citing works
Small Molecule — Protein Interactions
Waldmann, H., & Koppitz, M. (2003) · Springer eBooks · doi:10.1007/978-3-662-05314-0 · Cited by 15 · see citing works
Flotow, H., Leong, C., & Buss, A. D. (2002) · SLAS DISCOVERY · doi:10.1177/108705710200700409 · Cited by 13 · see citing works
Curtain has fallen on hopes of legal bioprospecting
Rosenthal, J. P. (2002) · Nature · doi:10.1038/416015a · Cited by 13 · see citing works
A Central Natural Product Pool — New Approach in Drug Discovery Strategies
Koch, C., Neumann, T., Thiericke, R., et al. (2000) · Springer eBooks · doi:10.1007/978-3-642-60250-4_3 · Cited by 12 · see citing works
The History of Penicillin Production
(1970) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600591144 · Cited by 7 · see citing works
Automation Strategies in Drug Discovery
Thiericke, R., Grabley, S., & Geschwill, K. (2000) · Springer eBooks · doi:10.1007/978-3-642-60250-4_4 · Cited by 5 · see citing works
Ng, R. (2003) · Wiley eBooks · doi:10.1002/0471722804 · Cited by 5 · see citing works
Fischli, A., PANDIT, U. K., & Black, D. S. (2002) · Pure and Applied Chemistry · doi:10.1351/pac200274040697 · Cited by 2 · see citing works
(2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1326 · Cited by 2 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Marine Natural Products: A Source of Novel Anticancer Drugs
Khalifa, S. A. M., Elias, N., Farag, M. A., Chen, L., Saeed, A., Hegazy, M.-E. F., Moustafa, M. S., Abd El-Wahed, A., Al-Mousawi, S. M., Musharraf, S. G., et al. (2019) · Marine Drugs · doi:10.3390/md17090491 · Cited by 555 · see citing works
“Natural products represent an available source of new drugs, drug leads and chemical entities [11,12].”
BackgroundSpampinato, C., & Leonardi, D. (2013) · BioMed Research International · doi:10.1155/2013/204237 · Cited by 411 · see citing works
Emerging Roles of Anacardic Acid and Its Derivatives: A Pharmacological Overview
Hemshekhar, M., Sebastin Santhosh, M., Kemparaju, K., & Girish, K. S. (2012) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2011.00833.x · Cited by 239 · see citing works
Ma, D., Zou, B., Cai, G., Hu, X., & Liu, J. O. (2006) · Chemistry – A European Journal · doi:10.1002/chem.200600599 · Cited by 99 · see citing works
Formulation and Evaluation of Antifungal Soap Using Latex of Calotropis gigantea L.
Kharnare, R. M., Bairagi, V. A., Chavhan, R. B., Shivde, T. S., Khalane, S. M., & Lengare, S. R. (2026) · International Journal of Research in Engineering, Science and Management · doi:10.65138/ijresm.v9i5.3451
“Personal cleansing products, particularly soaps, are the most common vehicles for maintaining hygiene; however, standard commercial soaps often lack specialized therapeutic properties required to treat localized infections [20]- [22].”
- Authors
- Butler, M. S.
- Affiliations
- MerLion Pharmaceuticals, 1 Science Park Road, The Capricorn #05-01, Singapore Science Park II, Singapore 117528
- Corresponding author
- Butler, Mark S.
- ORCID
- Butler, Mark S.
- Venue
- Journal of Natural Products
- Publisher
- American Chemical Society (ACS)
- Published
- 2004-11-23
- Volume
- 67
- Issue
- 12
- Pages
- 2141-2153
- ISSN
- 0163-3864 (ISSN-L)
- 1520-6025
- OpenAlex
- W2127597456
- Cited by
- 1,381
- References
- 113
- Citations by year
- 2026: 32 · 2025: 52 · 2024: 63 · 2023: 66 · 2022: 66 · 2021: 79 · 2020: 77 · 2019: 81 · 2018: 77 · 2017: 80 · 2016: 74 · 2015: 81 · 2014: 93 · 2013: 86 · 2012: 64
- FWCI
- 2.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Natural Products (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology › Microbial Natural Products and Biosynthesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioactive natural compounds
- Physical Sciences › Computer Science › Computational Theory and Mathematics › Computational Drug Discovery Methods
- Keywords
- natural products, drug discovery, natural product-derived drugs, pharmaceutical industry, natural product screening, natural product isolation, structure elucidation, natural extracts, lead compound identification, immunosuppression, anti-infective agents, metabolic disorders
- MeSH terms
- Biological Factors, Drug Industry, Drug Design, Molecular Structure, Combinatorial Chemistry Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review